FR2351664A2 - Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant - Google Patents

Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant

Info

Publication number
FR2351664A2
FR2351664A2 FR7615093A FR7615093A FR2351664A2 FR 2351664 A2 FR2351664 A2 FR 2351664A2 FR 7615093 A FR7615093 A FR 7615093A FR 7615093 A FR7615093 A FR 7615093A FR 2351664 A2 FR2351664 A2 FR 2351664A2
Authority
FR
France
Prior art keywords
fraction
crude extract
bacteria
extractable
walls
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7615093A
Other languages
English (en)
Inventor
Jean Choay
Mireille Sakouhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Priority to FR7615093A priority Critical patent/FR2351664A2/fr
Priority to US05/752,993 priority patent/US4148877A/en
Priority to JP15765376A priority patent/JPS5282713A/ja
Priority to DE19762659431 priority patent/DE2659431A1/de
Publication of FR2351664A2 publication Critical patent/FR2351664A2/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
FR7615093A 1975-12-29 1976-05-19 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant Pending FR2351664A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7615093A FR2351664A2 (fr) 1976-05-19 1976-05-19 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant
US05/752,993 US4148877A (en) 1975-12-29 1976-12-21 Fraction capable of inducing in vivo a resistance to bacterial infections, process for obtaining said fraction from bacteria and drugs containing said fraction
JP15765376A JPS5282713A (en) 1975-12-29 1976-12-28 Preparation of bioactive fraction and ittcontaining medicine
DE19762659431 DE2659431A1 (de) 1975-12-29 1976-12-29 Verfahren zur gewinnung einer atoxischen, biologisch aktiven fraktion, die dabei erhaltene fraktion und sie enthaltende arzneimittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7615093A FR2351664A2 (fr) 1976-05-19 1976-05-19 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant

Publications (1)

Publication Number Publication Date
FR2351664A2 true FR2351664A2 (fr) 1977-12-16

Family

ID=9173339

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7615093A Pending FR2351664A2 (fr) 1975-12-29 1976-05-19 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant

Country Status (1)

Country Link
FR (1) FR2351664A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
EP0013851A1 (fr) * 1978-12-19 1980-08-06 Pierre Fabre S.A. Protéoglycanes bactériens purifiés, procédé pour leur préparation et vaccin les contenant

Similar Documents

Publication Publication Date Title
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
ATE84964T1 (de) Haarregenerierende zubereitungen.
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
YU174491A (sh) Vakcine
ES2154265T3 (es) Tratamiento de la disenteria bacteriana.
AU538896B2 (en) Preparation of ribosomal rnas and immunostimulating preparations containing them
FR2444464B1 (fr)
PT600396E (pt) Vacinas contra protozoarios intestinais
ES547967A0 (es) Un procedimiento para preparar una composicion para el tra- tamiento de fuego bacteriano en plantas
EP1114826A3 (fr) Macrolides antibactériennes et prokinétiques
FR2336939A1 (fr) Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant
WO1999051256A3 (fr) Utilisation de l-glu-l-trp pour le traitement d'une infection par vih
WO1990013281A3 (fr) Procede de suppression d'une infection par l'hiv
DE10399019I1 (de) Gefluegelkrankheit verursachende neue Bakterie unddaraus stammender Impfstoff
EP0090660A3 (fr) Vaccin anti-gonococcique
EP0057349A3 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
EP0250115A3 (fr) Dérivés de 2,5-pyrrolidinediones obtenus à partir de bactérie et leur utilisation comme bactéricide
IT8121484A0 (it) Estratto da piante del genere epimedium, procedimento per lapreparazione di detto estratto, agente immunostimolante che comprende detto estratto come componente efficace e immunoterapia mediante l'impiego di detto estratto.
FI872459A7 (fi) Farmaseuttinen valmiste bakteeri-infektioiden hoitoon.
CA2122604A1 (fr) Utilisation de produits derives de l'aloes tels que l'acemannane dans le traitement de maladies dont la guerison necessite une intervention du systeme immunitaire
IE32044L (en) Tetanus vaccine
DK621688D0 (da) Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr
Tkacz et al. A comparison of mezlocillin and carbenicillin with respect to efficacy and tolerance for the treatment of bacterial infections.
JPS53109923A (en) Preparation of anti-tumor polysaccharides